Do: Use large-language AI to help analyze your specific symptoms. Don’t: Ask a chatbot if you should go to the emergency room.

If Congress doesn’t act soon, CMS’s flexible funding of telemedicine visits—a temporary holdover from the COVID era—will dry up next year. A new study may help persuade fiscally cautious representatives not to let that happen.

In a survey, employers told the Business Group on Health that they aren’t yet seeing evidence of long-term health benefits from taking GLP-1s for weight loss, leaving them unsure how to manage costs while continuing to cover them.

The user-friendly setup was designed with novice users in mind so that imaging can be completed quickly at the bedside, expediting diagnosis and treatment in urgent and emergency care. 

In late March, GE issued Urgent Medical Device Correction notices to customers believed to be affected by the software issue.

The new device from Arizona-based Corvention was built to withstand the extreme pressures associated with treating severely calcified valves. 

New findings question the use of artificial intelligence in these settings due to numerous shortcomings, including issues with overdetection and low specificity.

The company's Seismiq platform has already gained FDA approval for treating PAD. This new analysis highlights its potential to treat calcified coronary lesions during PCI procedures.

The American Society of Nuclear Cardiology visited Capitol Hill to advocate for a variety of issues. Cardiovascular Business spoke to the group's president to learn more.

Litt, a leading name in the fields of radiology and cardiology, has been with the journal since it was first launched in 2019.